U.S. District Judge Denise L. Cote wrote that the one-time “Pharma Bro” violated state and federal laws in exerting monopoly power over Daraprim, which is used to treat parasitic infections and HIV. (Photo: Diego M. Radzinschi/ALM)

Martin Shkreli — who earned the nickname “pharma bro” after his pharmaceutical company dramatically increased the price of an older drug, was sentenced to seven years in prison for securities fraud in 2017 and banned from the pharmaceutical industry for life — has been busy since his release from jail last year. He has developed a virtual health care assistant.

In an April 20 blog post, Shkreli said his new chatbot, dubbed DrGupta.AI (the logo on the website highlights the letters G, P, and T), would be able to help patients “access health information and simulate interactions with a physician.” For $20 a month, users can send unlimited messages to the chatbot, which is now available.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

Lynn Cavanaugh


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.